Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Simonneau (Le Kremlin-Bicêtre, France). Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study. 1984

Member's Comments

No comment yet.

Related content which might interest you: Macitentan in chronic thromboembolic pulmonary hypertension (CTEPH): experience from the OPUS registry Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study Source: Eur Respir J 2006; 28: 138-143 Year: 2006 Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019 Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN) Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Open label study of bosentan in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 706s Year: 2004 Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020 Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Initial results of the UK audit of chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2007; 30: Suppl. 51, 486s Year: 2007 The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003 Efficacy of riociguat in patients with inoperable CTEPH vs persistent/recurrent PH after pulmonary endarterectomy (PEA): Results from the phase III CHEST-1 study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012 Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry Source: ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020 Year: 2021 Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 First international registry on chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Bosentan for inoperable chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 399s Year: 2006